Description
+ Include: 38 videos + 37 pdfs, size: 10.1 GB
+ Target Audience: urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, and allied health professions
+ Sample video: contact me for sample video
+ Information:
Thursday, October 24, 2019, 12:00 PM – Saturday, October 26, 2019, 11:30 AM EST, Zuckerman Research Center, 417 East 68th Street, New York, NY
The course objective is to advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer. The program will include comprehensive state-of-the art lectures and discussions encouraging the exchange of ideas between faculty (radiologists, pathologists, surgeons, radiation oncologists, and medical oncologists) and the audience. Discussions will center on the multidisciplinary management of bladder and kidney cancer.
The intended audience includes urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, and allied health professions.
- To present a multidisciplinary approach to the management of bladder and kidney cancer including surgery, medical oncology, and radiation therapy.
- To advance and disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer
+ Topics:
2nd Line Therapy and Beyond- Approved Agents and Their Application in the Post-IO Space.mp4
2nd Line Therapy and Beyond- Approved Agents and Their Application in the Post-IO Space.pdf
Adjuvant Therapy for MIBC (Including Data on Standard and Novel Therapies).mp4
Adjuvant Therapy for MIBC (Including Data on Standard and Novel Therapies).pdf
Biopsy.mp4
Biopsy.pdf
Case Discussion I- BCG Shortage; Optimal BCG, Selection for Early Cystectomy; Persistent Positive Cytology (Natural History, Surveillance vs. Therapy).mp4
Case Discussion II- Multifocal Renal Masses, SRM in Elderly.mp4
Case Discussion II- Multifocal Renal Masses, SRM in Elderly.pdf
Case Discussion III- Large Renal Masses, Node Positive, Solitary Kidney.mp4
Case Discussion III- Large Renal Masses, Node Positive, Solitary Kidney.pdf
Case Discussions- Clinical Management of Histologic Variants.pdf
Case Discussions- Management of Metastatic Bladder Cancer in the Immunotherapy Era.mp4
Case Discussions- Management of Metastatic Bladder Cancer in the Immunotherapy Era.pdf
Case Discussions- Multidisciplinary Approaches to Metastatic Kidney Cancers.mp4
Case Discussions- The Role of Bladder Preservation in MIBC.mp4
Case Discussions- The Role of Bladder Preservation in MIBC.pdf
Case Discussions-RCC Management in the Metastatic Setting.mp4
Case Discussions-RCC Management in the Metastatic Setting.pdf
Cytoreduction + Metastasectomy.mp4
Cytoreduction + Metastasectomy.pdf
Emerging Paradigms in the Upfront Management of Metastatic Kidney Cancer.mp4
Emerging Paradigms in the Upfront Management of Metastatic Kidney Cancer.pdf
Emerging Regimens for Metastatic RCC.mp4
Emerging Regimens for Metastatic RCC.pdf
Familial Predisposition Syndromes and Germline Testing in RCC.mp4
Familial Predisposition Syndromes and Germline Testing in RCC.pdf
Histologic Variants of Bladder Cancer.mp4
Histologic Variants of Bladder Cancer.pdf
Importance of Germline Mutations in Urothelial Cancer.mp4
Importance of Germline Mutations in Urothelial Cancer.pdf
IO Therapy for Advanced Bladder Cancer- Data for IO in the 1st Line Metastatic Setting.mp4
IO Therapy for Advanced Bladder Cancer- Data for IO in the 1st Line Metastatic Setting.pdf
IO Tox Management.mp4
IO Tox Management.pdf
LN Dissection.mp4
LN Dissection.pdf
Management of BCG – Unresponsive NMIBC.mp4
Management of BCG – Unresponsive NMIBC.pdf
Molecular Biology of MIBC – Role in Bladder Preservation.mp4
Molecular Biology of MIBC – Role in Bladder Preservation.pdf
Neoadjuvant Therapy for Cis-eligible Patients (Cisplatin-based Chemotherapy, IO+Chemotherapy Trials).mp4
Neoadjuvant Therapy for Cis-eligible Patients (Cisplatin-based Chemotherapy, IO+Chemotherapy Trials).pdf
New Detection Technologies- Blue Light and NBI.mp4
New Detection Technologies- Blue Light and NBI.pdf
NMIBC Molecular Biology.mp4
NMIBC Molecular Biology.pdf
Novel Imaging in RCC.mp4
Novel Imaging in RCC.pdf
Open vs Robotic Surgery for MIBC- Update of Current Data.mp4
Partial vs Radical for -= pT1b.mp4
Partial vs Radical for -= pT1b.pdf
Perioperative Therapy in the Non-metastatic Setting.mp4
Perioperative Therapy in the Non-metastatic Setting.pdf
Predictive Biomarkers and Novel Metastatic Options (ADC, FGFR3 Inhibition).mp4
Predictive Biomarkers and Novel Metastatic Options (ADC, FGFR3 Inhibition).pdf
RARC- How to. Tips and Tricks.mp4
RARC- How to. Tips and Tricks.pdf
Risk Stratification and Molecular Classifiers in the Metastatic Setting.mp4
Risk Stratification and Molecular Classifiers in the Metastatic Setting.pdf
Role of Checkpoint Inhibitors for NMIBC.mp4
Role of Checkpoint Inhibitors for NMIBC.pdf
SRM – Epidemiology and Treatment Molecular (Overtreatment).mp4
SRM – Epidemiology and Treatment Molecular (Overtreatment).pdf
Surgical Safety in IO Treated Patients.mp4
Surgical Safety in IO Treated Patients.pdf
Surveillance and Genomics.mp4
Surveillance and Genomics.pdf
Systemic Therapy for Metastatic Non-clear Cell RCC.mp4
Systemic Therapy for Metastatic Non-clear Cell RCC.pdf
Trimodal Therapy for MIBC.mp4
Trimodal Therapy for MIBC.pdf
Upper Tract TCC Molecular Differences and Clinical Management of UTUC.mp4
Upper Tract TCC Molecular Differences and Clinical Management of UTUC.pdf
Urology2019_Brochure.pdf
Reviews
There are no reviews yet.